PAK BioSolutions
Burke, US · Founded 2019 · Delaware corporation · 19 employees on LinkedIn · 1 known investors
Find your way into PAK BioSolutions
Sign up to find every way you can get introduced to PAK BioSolutions
- Your email: who you already know at PAK BioSolutions, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the PAK BioSolutions team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
PAK BioSolutions builds automated systems and single-use flow kits for end-to-end continuous purification of biopharmaceuticals, running four continuous purification stages simultaneously for a stated 4X productivity gain over batch methods. Its equipment and GMP consumables serve biopharmaceutical manufacturers for both laboratory and GMP production.
Founders & leadership
Investors · 1
How we know: Arboretum Ventures's portfolio page · the company's own site · funding news · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5M disclosed across 2 rounds · 2019–2024
▶$5MraisedJun 2024 · 2 investors · Other TechnologyRule 506(b)
- Joanna PezziniExecutive Officer, Director
- Daniel KidleDirector
- Kevin Hill-ByrneExecutive Officer, Director
- Charles PurtellDirector
- Offering amount
- $8.5M
- Amount sold
- $5M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$30KraisedJul 2019 · 3 investors · Other TechnologyRule 506(b)
- Pezzini JoannaExecutive Officer
- Kevin Hill-ByrneExecutive Officer
- Offering amount
- $300K
- Amount sold
- $30K
- Proceeds to insiders
- $30.2K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as PAK BioSolutions.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $325K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does PAK BioSolutions do?
- PAK BioSolutions builds automated systems and single-use flow kits for end-to-end continuous purification of biopharmaceuticals, running four continuous purification stages simultaneously for a stated 4X productivity gain over batch methods. Its equipment and GMP consumables serve biopharmaceutical manufacturers for both laboratory and GMP production.
- Who are PAK BioSolutions's investors?
- PAK BioSolutions's investors include Arboretum Ventures.
- How much funding has PAK BioSolutions raised?
- PAK BioSolutions has disclosed $5M raised across 2 rounds.
- Where is PAK BioSolutions headquartered?
- PAK BioSolutions is headquartered in Burke, US.



